The company specializes in investing in biotech and healthcare companies, primarily in the United States. They focus on late-stage companies with approved products or products in advanced stages of development. However, they also consider early-stage companies with promising technology or business strategies. In addition to direct equity investments, the firm may form entities to secure rights for developing, manufacturing, and marketing company products in selected Asian markets.